|
VPS33A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.643800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.618500E-04 |
| Normal-vs-Stage2 |
2.813000E-01 |
| Normal-vs-Stage3 |
4.717200E-01 |
| Normal-vs-Stage4 |
1.823840E-01 |
| Stage1-vs-Stage2 |
2.290600E-01 |
| Stage1-vs-Stage3 |
4.555600E-02 |
| Stage1-vs-Stage4 |
3.991800E-01 |
| Stage2-vs-Stage3 |
6.876800E-01 |
| Stage2-vs-Stage4 |
8.233800E-01 |
| Stage3-vs-Stage4 |
4.945000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.298700E-03 |
| Normal-vs-AfricanAmerican |
6.959200E-01 |
| Normal-vs-Asian |
2.732800E-01 |
| Caucasian-vs-AfricanAmerican |
2.065000E-01 |
| Caucasian-vs-Asian |
4.646400E-01 |
| AfricanAmerican-vs-Asian |
2.185400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.958200E-02 |
| Normal-vs-Female |
7.124300E-03 |
| Male-vs-Female |
4.531200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.043000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.950270E-02 |
| Normal-vs-Age(61-80Yrs) |
5.120500E-03 |
| Normal-vs-Age(81-100Yrs) |
9.659400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.181850E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.834000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.540800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.174600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.997400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.415400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.216400E-02 |
| Normal-vs-Grade 2 |
1.244510E-03 |
| Normal-vs-Grade 3 |
7.802000E-02 |
| Normal-vs-Grade 4 |
5.333800E-01 |
| Grade 1-vs-Grade 2 |
6.793000E-01 |
| Grade 1-vs-Grade 3 |
1.861810E-01 |
| Grade 1-vs-Grade 4 |
1.429170E-01 |
| Grade 2-vs-Grade 3 |
1.644220E-01 |
| Grade 2-vs-Grade 4 |
1.765980E-01 |
| Grade 3-vs-Grade 4 |
6.135400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.25750000000847E-05 |
| Normal-vs-ccB subtype |
1.790840E-01 |
| ccA subtype-vs-ccB subtype |
3.321700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.144280E-02 |
| Normal-vs-N1 |
3.424000E-01 |
| N0-vs-N1 |
7.413400E-01 |
|
|
